Hi @Davisite,
congratulations to the Race team on some more great results! I have a couple of questions on the 2 charts.
Can you expand on why in Figure 2 the data was divided into those three "buckets"? Is there any particular significance to the 2-fold improvement value?
Also, I didn't see any mention of how the cell lines that showed greater (or no) improvement (Figure 2) relate to the types of cancer shown in Figure 1., why is that?
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-83
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |